Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18125121 | 1.00 | TSHR (0.48) | TSHRALDH1A1MEN1CYP3A4ALOX15 | |
| SCHEMBL3897447 | 0.87 | TSHR (0.46) | TSHRALDH1A1MEN1CYP3A4ALOX15 | |
| SCHEMBL13839555 | 0.87 | TSHR (0.46) | TSHRALDH1A1MEN1CYP3A4ALOX15 | |
| SCHEMBL11651471 | 0.83 | TSHR (0.42) | TSHRALDH1A1MEN1CYP3A4ALOX15 | |
| SCHEMBL8719687 | 0.82 | TSHR (0.34) | TSHRALDH1A1TDP1 | |
| SCHEMBL29255967 | 0.81 | TSHR (0.65) | TSHRALDH1A1 | |
| SCHEMBL29011335 | 0.81 | TSHR (0.41) | TSHRALDH1A1MEN1CYP3A4ALOX15 | |
| SCHEMBL4036012 | 0.81 | TSHR (0.50) | TSHRTDP1 | |
| SCHEMBL4041345 | 0.81 | TSHR (0.50) | TSHRTDP1 | |
| SCHEMBL2146861 | 0.81 | TSHR (0.50) | TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1165058-B1 | AZALIDE ANTIBIOTICS FOR THE TOPICAL TREATMENT OR PREVENTION OF OCULAR INFECTIONS | INSITE VISION INC (US) | 2005-05-25 | — | — | EP | claimed |
| CN-1110541-C | Concentrated water-dispersible stable fiber softener compositions | PROCTER & GAMBLE (US) | 2003-06-04 | — | — | CN | claimed |
| CN-1098350-C | Fabric softening compound/composition | PROCTER & GAMBLE (US) | 2003-01-08 | — | — | CN | claimed |
| CN-1244212-A | Improved expression vectors | PROCTER & GAMBLE (US) | 2000-02-09 | — | — | CN | claimed |
| CN-1219953-A | Fabric softening compound/composition | PROCTER & GAMBLE (US) | 1999-06-16 | — | — | CN | claimed |
| CN-1196081-A | Concentrated, water dispersible, stable, fabric softening compositions | PROCTER & GAMBLE (US) | 1998-10-14 | — | — | CN | claimed |
| CN-1195369-A | Concentrated and stable fabric softening compositions | PROCTER & GAMBLE (US) | 1998-10-07 | — | — | CN | claimed |
| CN-116456984-A | Stable crystalline hydrate of claritan disodium salt | 爱杜西亚药品有限公司 | 2023-07-18 | — | — | CN | disclosed |
| CN-108367348-B | Metal nanoparticle dispersions | 爱克发-格法特公司 | 2021-05-07 | — | — | CN | disclosed |
| US-20170281627-A1 | TOLL LIKE RECEPTOR MODULATOR COMPOUNDS | GILEAD SCIENCES, INC. | 2017-10-05 | — | — | US | disclosed |
| US-9670205-B2 | Toll like receptor modulator compounds | GILEAD SCIENCES, INC. (US) | 2017-06-06 | — | — | US | disclosed |
| US-20170071944-A1 | MODULATORS OF TOLL-LIKE RECEPTORS FOR THE TREATMENT OF HIV | GILEAD SCIENCES, INC. | 2017-03-16 | — | — | US | disclosed |
| US-20160289229-A1 | TOLL LIKE RECEPTOR MODULATOR COMPOUNDS | GILEAD SCIENCES, INC. | 2016-10-06 | — | — | US | disclosed |
| EP-0839180-A1 | CONCENTRATED, STABLE FABRIC SOFTENING COMPOSITIONS INCLUDING CHELANTS | THE PROCTER & GAMBLE COMPANY (US) | 1998-05-06 | — | — | EP | disclosed |
| WO-1998002513-A1 | SUBSTANTIALLY ODOR-FREE POLYHYDROXYL SOLVENTS | THE PROCTER & GAMBLE COMPANY (US) | 1998-01-22 | — | — | WO | disclosed |
| WO-1997034972-A1 | FABRIC SOFTENING COMPOUND/COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 1997-09-25 | — | — | WO | disclosed |
| WO-1997003172-A1 | CONCENTRATED, STABLE FABRIC SOFTENING COMPOSITIONS INCLUDING CHELANTS | THE PROCTER & GAMBLE COMPANY (US) | 1997-01-30 | — | — | WO | disclosed |
| WO-1997003169-A1 | CONCENTRATED, STABLE FABRIC SOFTENING COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 1997-01-30 | — | — | WO | disclosed |
| US-5132367-A | Compositions obtained by curing an acetoacetylated poly(meth)acrylic or polyester-based resin and an isocyanate-free polyurethane | GUERTIN BROS. COATINGS AND SEALANTS LTD. (CA) | 1992-07-21 | — | — | US | disclosed |
| EP-0098241-B1 | HYDROQUINONE ETHERS AND A PROCESS FOR PREPARING THEM | CIBA-GEIGY AG (CH) | 1985-10-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170281627-A1 | TOLL LIKE RECEPTOR MODULATOR COMPOUNDS | TLR8, TLR3, TLR6 | TSHR 1106/4885ALDH1A1 3811/4885MEN1 4835/4885 |
| US-20160289229-A1 | TOLL LIKE RECEPTOR MODULATOR COMPOUNDS | TLR8, TLR3, TLR6 | TSHR 1106/4885ALDH1A1 3811/4885MEN1 4835/4885 |
| US-20170071944-A1 | MODULATORS OF TOLL-LIKE RECEPTORS FOR THE TREATMENT OF HIV | TLR8, TLR3, TLR6 | TSHR 2756/4885ALDH1A1 3939/4885MEN1 4877/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.